Society for Endocrinology - a world-leading authority on hormones

Solvay ends research on obesity treatment compound (Reuters, 17 November 2008)

17 Nov 2008


The Belgian drugs company Solvay, has announced it is ending its research into SLV319, a compound for the treatment of obesity.

Full article